KRUSE BO (EVP, CFO, Secy & Treas.) sold 2.0% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $68.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2022ACC: 0001104659-22-001565
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$68.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$17.12
Trade value
$68.48K
% of position
2.0%
1/4/2022
197.08K→193.08K
Total
Net shares
−4K
Net value
-$68.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2022 | S · Sale | −4K | $17.12 | $68.48K | 2.0% | 197.08K | 193.08K |
| Total | −4K | -$68.48K | ||||||
Derivative Transactions0
No derivative transactions reported